Glyburide (Glyburide) - Adverse Event Reports - Disability

Confusional State (1),  Blood Creatine Phosphokinase Increased (1),  Cataract (1),  Nausea (1),  Hyperglycaemia (1),  Intentional Self-Injury (1),  Somnolence (1),  Convulsion (1),  Dysarthria (1),  Suicide Attempt (1)

Adverse event in receiving Glyburide

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Confusional State, Abdominal Pain, Agitation, Blood Creatine Phosphokinase Increased, Hypoglycaemia, Pain, Tachycardia, Coma, Pyrexia, Intentional Drug Misuse, Acidosis, Somnolence, Hyperhidrosis, Intentional Self-Injury, Overdose, Medication Error, Blood Electrolytes Abnormal, Dizziness, Coordination Abnormal, Vomiting, Nausea, Hyperglycaemia, Convulsion, Dysarthria, Syncope, Renal Failure, Diarrhoea, Suicide Attempt, Bradycardia, Hypertension

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Glyburide

Adverse event in 24 year old male receiving Glyburide

Reported by a individual with unspecified qualification from Japan on 2007-04-16

Patient: 24 year old male

Adverse reactions / side effects: Cataract, Body Mass Index Increased, Insulin Resistance, Pallanaesthesia

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Actos
    Dosage: 15 mg (15 mg, 1 in 1d) per oral
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-07-19
    End date: 2006-07-25

Glufast (Mitiglinide Calcium Hydrate)
    Dosage: see image
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-07-25
    End date: 2006-09-11

Glufast (Mitiglinide Calcium Hydrate)
    Dosage: see image
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-09-11
    End date: 2006-10-13

Glyburide
    Dosage: 2.5 mg (2.5 mg, 1 in 1 d) per oral
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-07-19
    End date: 2006-07-25

Metformin Hydrochloride
    Dosage: 500 mg (250 mg, 2 in 1 d) per oral
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent
    Start date: 2006-07-25
    End date: 2006-11-15